Context

The brand is a Chengdu-based health and wellness company producing a product line around sleep, stress, and daily nutritional support. Strong product credentials — clinical ingredient sourcing, transparent manufacturing documentation. The Benelux was identified as the entry target: the Netherlands and Belgium have among the highest per-capita health supplement spend in Europe, with a consumer base that skews educated, research-led, and open to efficacy-driven brands regardless of origin.

Boostway engagement

Market Entry & Expansion + Brand Visibility & Authority. 12-month engagement. The content-first strategy was chosen specifically because of EU health supplement advertising restrictions — health claim advertising is heavily regulated under EU Regulation 1924/2006, making direct product benefit claims in paid media legally complex. Content marketing is the primary compliant path to health product authority building in the EU.

The Challenge

EU health supplement marketing is unusually constrained. Unlike US health marketing where benefit claims can be freely made (with standard disclaimers), EU regulation requires that health claims be approved on an authorised list. Most of the claims a Chinese supplement brand would want to make — "supports immune function," "improves sleep quality" — are either on the restricted list or require specific clinical evidence thresholds to use in marketing.

This isn't a barrier for brands with expertise content strategies. It is, however, a near-complete barrier for brands relying on paid social advertising with benefit-led creative. The Benelux market rewards brands that demonstrate expertise and ingredient transparency. Chinese health brands that try to compete on benefit advertising hit the regulatory wall; brands that compete on education win the market.

"EU supplement regulation isn't a problem for brands with genuine expertise. It's a barrier for brands without it — which means the brands that do the educational content work face less competition from those that can't."

The Strategy

Phase 1 — Regulatory and Content Infrastructure (Months 1–3)

EU regulatory review of all product claims: full audit against EFSA approved health claims register, reformulation of marketing copy to use only compliant claims, legal review of product labels. Dutch and French-language versions of product pages and all marketing materials.

Content programme: 12 long-form educational articles written by a Dutch-language health writer, covering the specific ingredient mechanisms, research basis, and consumer questions in the product category. Not product promotion — genuine educational content that positions the brand as a category expert. Published across a blog and distributed via Dutch and Belgian health-focused editorial channels.

Phase 2 — Review and Trust Infrastructure (Months 2–5)

Bol.com (Netherlands' dominant e-commerce platform) profile established and seeded with initial review cohort — Bol.com is the Trustpilot equivalent for product trust in Dutch markets. Google Shopping feed built with local pricing and Dutch-language copy. Partnership with two Dutch nutrition and wellness content creators for long-form product review content (not promotional — structured review format with full ingredient analysis).

Phase 3 — Acquisition and Scale (Months 5–12)

Google Search campaigns targeting educational query terms — buyers searching for ingredient information, not product names. Conversion path: search → educational blog content → product page → purchase. The content provided the authority signal that the product page alone could not. Buyers who arrived via content converted at 4.1% — significantly above the category average — because the education had already done the trust work.

4.1%

Conversion rate for content-led traffic

€18

Blended CAC for the full year (incl. content costs)

41%

Of total revenue attributed to content-led acquisition path

The content compounding effect

By month 12, the 12 educational content pieces were generating 2,800 organic monthly sessions with zero ongoing cost. Each organic session converting at 4.1% produces approximately €28 of revenue per session at the brand's average order value. The organic content ROI — calculated at year-end — was 6.8x on content production costs alone. The content continues to produce revenue into year two without additional investment.

The Results

€890K

First-year Benelux revenue

3.6x

ROI on total engagement investment

6.8x

Content production ROI at year end

Key Takeaways

  • EU health supplement regulation is not an obstacle — it is a competitive moat for brands that understand it. The brands complying with EFSA regulations face less paid-media competition from non-compliant competitors who can't run legally.
  • Content-first acquisition produces lower CAC than paid-only acquisition in high-trust categories — health, wellness, supplements — because the content does the authority work that paid ads alone cannot.
  • The Benelux is a high-value, lower-competition entry market for health and wellness brands. Dutch and Belgian consumers are sophisticated health buyers with above-average supplement spend who respond to transparency and ingredient depth.
  • Bol.com is not optional for physical product brands entering the Netherlands. It functions as both a sales channel and a trust signal — Dutch buyers check Bol.com product ratings even when they intend to purchase DTC.